SoftOx Solutions AS
OSE:SOFTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
SoftOx Solutions AS
Net Issuance of Common Stock
SoftOx Solutions AS
Net Issuance of Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
SoftOx Solutions AS
OSE:SOFTX
|
Net Issuance of Common Stock
kr33.8m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
|
Photocure ASA
OSE:PHO
|
Net Issuance of Common Stock
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
V
|
Vistin Pharma ASA
OSE:VISTN
|
Net Issuance of Common Stock
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
N
|
Navamedic ASA
OSE:NAVA
|
Net Issuance of Common Stock
kr130.2m
|
CAGR 3-Years
377%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
O
|
Oncoinvent ASA
OSE:ONCIN
|
Net Issuance of Common Stock
kr0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
SoftOx Solutions AS
Glance View
SoftOx Solutions AS engages in research and product development. The company is headquartered in Fornebu, Akershus. The company went IPO on 2018-06-01. The company is a developer of infection control solutions for disinfection, wound care and the respiratory tract. The current business segments can be divided into: Wounds, Disinfection and Respiratory. SoftOx Solutions is engaged in the development of a range of products that can be classified as either medical devices or medicinal products for human use. SoftOx’s product portfolio includes such products as SafeDes+, a hand disinfectant for irritated, compromised and eczematous skin. The firm has several subsidiaries, including SoftOx Disinfection AS, SoftOx Defense Solutions AS and SoftOx Denmark AS.
See Also
What is SoftOx Solutions AS's Net Issuance of Common Stock?
Net Issuance of Common Stock
33.8m
NOK
Based on the financial report for Jun 30, 2025, SoftOx Solutions AS's Net Issuance of Common Stock amounts to 33.8m NOK.
What is SoftOx Solutions AS's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 5Y
-14%
Over the last year, the Net Issuance of Common Stock growth was 207%. The average annual Net Issuance of Common Stock growth rates for SoftOx Solutions AS have been -11% over the past three years , -14% over the past five years .
